Drug intelligence / Profile preview

morphine + ketorolac

Development stage
Unknown
Modality
Small Molecules
Administration
Intravenous, Intramuscular
01

Overview

Morphine + ketorolac is a combination of two analgesic drugs used primarily for the management of moderate to severe acute pain, especially in postoperative settings. Morphine is an opioid agonist that acts mainly on the mu-opioid receptor to provide potent analgesia by inhibiting pain transmission in the central nervous system. Ketorolac is a nonsteroidal anti-inflammatory drug (NSAID) that provides analgesic, anti-inflammatory, and antipyretic effects through non-selective inhibition of cyclooxygenase (COX-1 and COX-2), thereby reducing prostaglandin synthesis. The combination leverages both opioid and non-opioid mechanisms for enhanced pain control while allowing lower doses of each agent, which can reduce opioid-related adverse events such as urinary retention and sedation. Clinical studies have shown this combination to be more effective than either drug alone for postoperative pain relief, with reduced total consumption of both drugs and fewer side effects associated with higher-dose opioids[1][2][9].

Other names
morphine chloride + ketorolac tromethamine
02

Targets

PTGS2 (Prostaglandin-Endoperoxide Synthase 2)PGHS-1 (Prostaglandin G/H Synthase 1)MOR (Mu opioid receptor)

Beyond the preview

Go deeper on morphine + ketorolac.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on morphine + ketorolac.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call